Access

Under Access, we share best practice guidance on how to expand access to safe abortion and post-abortion care.

view all

Awareness

An estimated 25 million unsafe abortions occur every year. Under Awareness, we share strategies for increasing awareness of safe services.

view all

Quality

Under Quality, we share resources for delivering high-quality clinical care in safe abortion and post-abortion care programming.

view all

Policy

Under Policy, we share guidance and resources for overcoming common barriers to safe services and care.

view all
sign up for updates

12 Mar 2021

Medical Abortion and Self-Managed Abortion: Frequently Asked Questions

Ipas, Center for Reproductive Rights

Topics:

Medical Abortion (MA), Self-administration

Ipas and the Center for Reproductive Rights have developed a fact sheet answering frequently asked questions about medical abortion (also known as medication abortion or abortion will pills) and the self-management of abortion.

Questions covered in the fact sheet include:

  • What is a medical abortion and self-managed abortion?
  • How safe and effective is a medical abortion?
  • What do international human rights bodies say about these topics?

The FAQ document also addresses the impact of the COVID-19 pandemic on self-managed abortions and a set of recommendations that, if implemented, would improve access to services and respect, protect and fulfil human rights.

You can download the factsheets in English, French and Spanish via the Center for Reproductive Rights’ website.

If you’d like to find out more on the self-management of medical abortion, you might also be interested in the following:

Close comments

view comments

Sign up

Subscribe to our newsletter to receive the latest SafeAccess articles, straight to your inbox.

sign up

By clicking 'subscribe' you are accepting the terms and conditions of our privacy policy, and consent to receive email updates from SafeAccess. We will not sell your data, and promise to keep your information safe.

Error!

Success! You have successfully subscribed to the list.